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Figure S1. The Ac/N-End Rule Pathway, the Arg/N-End Rule Pathway, and the Steric 
Sequestration of N
α
-Terminally Acetylated N-Termini of Cellular Proteins. 
(A) The Ac/N-end rule pathway in the yeast Saccharomyces cerevisiae (Hwang et al., 
2010b; Varshavsky, 2011). N-terminal residues are indicated by single-letter abbreviations for 
amino acids. A yellow oval denotes the rest of a protein substrate. E3 ubiquitin (Ub) ligases of the 
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N-end rule pathway are called N-recognins. The Doa10 E3 N-recognin physically binds to 
N
α
-terminally acetylated (Nt-acetylated) polypeptides and contributes to the in vivo degradation of 
previously examined Nt-acetylated proteins (Hwang et al., 2010b). In the present study, we 
identified Not4 as a putative second N-recognin of the Ac/N-end rule pathway (Figure 2 and 
Discussion). Red arrow on the left indicates the removal of N-terminal Met by 
Met-aminopeptidases (MetAPs). N-terminal Met is retained if a residue at position 2 is 
nonpermissive (too large) for MetAPs ((Varshavsky, 2011) and references therein). If the retained 
N-terminal Met or N-terminal Ala, Val, Ser, Thr, and Cys are followed by acetylation-permissive 
residues, the cited N-terminal residues are usually Nt-acetylated by the Nt-acetylases NatA-NatD, 
the bulk of which is associated with the ribosomes (Arnesen et al., 2009; Starheim et al., 2012; Van 
Damme et al., 2012). Although second-position Gly or Pro can be made N-terminal by MetAPs and 
although the Doa10 E3 N-recognin can recognize Nt-acetylated Gly or Pro (Hwang et al., 2010b), 
few proteins with N-terminal Gly or Pro are Nt-acetylated. See Figure S2 for a summary of 
Nt-acetylation vis-à-vis specific N-terminal residues. The Nt-acetylation-mediated N-degrons are 
called Ac/N-degrons, to distinguish them from other N-degrons. The term “secondary” refers to the 
requirement for a modification (Nt-acetylation) of a destabilizing N-terminal residue before a 
protein can be recognized by a cognate N-recognin. Physiological functions of the Ac/N-end rule 
pathway are discussed in the main text. 
(B) The Arg/N-end rule pathway in S. cerevisiae (Varshavsky, 2011). The Ubr1/Rad6 E3-E2 
N-recognin Ub ligase directly recognizes (binds to) the “primary” destabilizing N-terminal residues 
Arg, Lys, His, Leu, Phe, Tyr, Trp and Ile. In contrast, N-terminal Asn, Gln, Asp, and Glu (as well as 
Cys, under some metabolic conditions) are destabilizing owing to their preliminary enzymatic 
modifications. These include the Nt-deamidation of N-terminal Asn and Gln by the Nta1 
Nt-amidase and the Nt-arginylation of N-terminal Asp and Glu by the Ate1 arginyltransferase 
(R-transferase), which can also Nt-arginylate oxidized Cys, either Cys-sulfinate or Cys-sulfonate. 
These derivatives of N-terminal Cys can form in cells that produce nitric oxide (NO) and may also 
form in S. cerevisiae. One aspect of the S. cerevisiae Arg/N-end rule pathway that is not illustrated 
in this diagram is a physical and functional interaction between the Ubr1 E3 of the Arg/N-end rule 
pathway and the Ufd4 E3 of the previously characterized Ub-fusion-degradation (UFD) pathway. 
Specifically, the targeting apparatus of the Arg/N-end rule pathway comprises a physical complex 
of the RING-type E3 Ubr1 N-recognin and the HECT-type E3 Ufd4, together with their cognate E2 
enzymes Rad6 and Ubc4 (or Ubc5), respectively (Hwang et al., 2010a). In addition to its two 
distinct binding sites that recognize type 1 (basic) and type 2 (bulky hydrophobic) destabilizing 
N-terminal residues, the S. cerevisiae Ubr1 N-recognin also contains (similarly to its counterparts in 
multicellular eukaryotes) at least one more binding site, which recognizes substrates that are 
targeted through their internal (non-N-terminal) degradation signals. One example of such a 
substrate is the Cup9 transcriptional repressor (Byrd et al., 1998; Turner et al., 2000; Xia et al., 
2008a). Polyubiquitylated N-end rule substrates are processively destroyed to short peptides by the 
26S proteasome. Hemin (Fe
3+
-heme) binds to R-transferase and inhibits its Nt-arginylation activity. 
Hemin also binds to Ubr1 and alters its functional properties, in ways that remain to be understood 
(Hu et al., 2008). 
Regulated degradation of specific proteins by the Arg/N-end rule pathway mediates the 
sensing of heme, NO, oxygen and short peptides; the selective elimination of misfolded proteins; 
the regulation of DNA repair; the cohesion/segregation of chromosomes; the signaling by 
transmembrane receptors; the control of peptide import; the regulation of apoptosis, meiosis, viral 
and bacterial infections, fat metabolism, cell migration, actin filaments, cardiovascular development, 
spermatogenesis, neurogenesis, and memory; the functioning of adult organs, including the brain, 
muscle, testis, and pancreas; and the regulation of leaf and shoot development, leaf senescence, and 
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many other functions in plants ((Brower and Varshavsky, 2009; Choi et al., 2010; Dougan et al., 
2011; Eisele and Wolf, 2008; Gibbs et al., 2011; Graciet and Wellmer, 2010; Heck et al., 2010; Hu 
et al., 2005; Hu et al., 2008; Hwang et al., 2009; Hwang et al., 2010a; Hwang et al., 2011; Hwang 
and Varshavsky, 2008; Kurosaka et al., 2010; Kwon et al., 2002; Lee et al., 2012; Lee et al., 2005; 
Licausi et al., 2011; Matta-Camacho et al., 2010; Mogk et al., 2007; Piatkov et al., 2012a; Piatkov et 
al., 2012b; Prasad et al., 2010; Rao et al., 2001; Sasidharan and Mustroph, 2011; Tasaki et al., 2012; 
Varshavsky, 1996, 2011; Wang et al., 2009; Xia et al., 2008b; Zenker et al., 2005; Zhang et al., 
2010a) and references therein). 
(C) Steric shielding of the Nt-acetylated N-terminal residue of a subunit in a protein 
complex. Shown here is a part of the crystal structure, by the Barford laboratory, of a complex 
between the Hcn1 and Cut9 subunits of the Schizosaccharomyces pombe APC/C Ub ligase (Zhang 
et al., 2010b). In this structure, the (indicated) Nt-acetylated N-terminal Met residue of Hcn1 is 
enclosed within a deep cleft formed by the Cut9 subunit, in the heterotetramer of Hcn1 and Cut9. 
The N-terminal region of Hcn1 is shown in cyan as a stick model, and Cut9 is depicted as a cut-out 
surface representation, to show the chamber’s interior (Zhang et al., 2010b).  
(D) Model of interactions, based on single-particle electron microscopy by the Hughson 
laboratory, among the subunits Cog1-Cog4 that form a specific subcomplex of the S. cerevisiae 
COG complex (Lees et al., 2010). The head of an arrow and its blunt end indicate the C-terminus 
and the N-terminus of a protein, respectively. The green, red, yellow, and blue arrows denote Cog1, 
Cog2, Cog3 and Cog4, respectively (Lees et al., 2010). Figure S1 refers to Figures 1, 3 and 5. 
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Figure S2. N-terminal Processing of Nascent Proteins, the N-termini of COG Subunits, and the 
N
α
-Terminal Acetylation in S. cerevisiae.  
(A) N-terminal processing of nascent cellular proteins by N
α
-terminal acetylases 
(Nt-acetylases) and Met-aminopeptidases (MetAPs). “Ac” denotes the Nα-terminal acetyl moiety. 
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M, Met. X and Z, single-letter abbreviations for any amino acid residue. Yellow ovals denote the 
rest of a protein. 
(B) The first 5 encoded N-terminal residues of the Cog1-Cog8 subunits of the Conserved 
Oligomeric Golgi (COG) complex in S. cerevisiae (Miller and Ungar, 2012; Sztul and Lupashin, 
2009). The Nt-acetylation status of the seven COG subunits (Cog2-Cog8) other than MD-Cog1
wt
 
remains to be determined. Save for Cog3, all of these subunits are candidates for Nt-acetylation in 
wild-type (wt) cells. 
 (C) Substrate specificities and subunit compositions of S. cerevisiae Nt-acetylases. This 
compilation is derived from data in the literature ((Arnesen et al., 2009; Helbig et al., 2010; 
Polevoda and Sherman, 2003; Starheim et al., 2012; Van Damme et al., 2012) and references 
therein). The present paper uses the revised nomenclature for specific subunits of Nt-acetylases 
(Polevoda et al., 2009) and cites the older names of these subunits in parentheses. Figure S2 refers 
to Figures 1 and 6. 
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Figure S3. Degradation of Cog1 by the Ac/N-End Rule Pathway. 
(A) Cycloheximide (CHX)-chases (related to the ones described in Figure 1) were carried 
out at 30°C with wt (lanes 1-3), doa10Δ (lanes 4-6) and naa20Δ (nat3Δ) (lanes 7-9) S. cerevisiae 
strains that expressed wt Cog1, termed MD-Cog1
wt
, which was C-terminally tagged with three flag 
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epitopes. At the indicated times of chase, proteins in cell extracts were fractionated by SDS-PAGE 
and assayed by immunoblotting with anti-Flag antibody. 
(B) CHX-chases as in A, with wt cells that expressed MD-Cog1
wt
 (lanes 1-3) or its 
non-Nt-acetylatable P-Cog1 mutant (lane 4-6), both of which were C-terminally tagged with three 
flag epitopes. See the main text for descriptions of P-Cog1. Asterisk on the left denotes a 
crossreacting protein. 
(C) CHX-chases as in A, with MD-Cog1
wt
 C-terminally ha-tagged and examined in naa50Δ 
(nat5Δ) (lanes 1-3), naa40Δ (nat4Δ) (lanes 4-6), naa20Δ (nat3Δ) (lanes 7-9), naa30Δ (mak3Δ) 
(lanes 10-12), and naa10Δ (ard1Δ) (lanes 13-15) S. cerevisiae strains. Each of these strains lacked 
the activity of a specific Nt-acetylase (see Figure S2C), including the cognate (for MD-Cog1
wt
) 
NatB Nt-acetylase (lanes 7-9). 
(D) Left panel: Expression of MD-Cog1
wt
 C-terminally tagged with three flag epitopes in 
pdr5Δ S. cerevisiae. Cells were incubated for 1 hr in SD medium containing either 
0.5% dimethylsulfoxide (DMSO) (the solvent for a stock solution of the proteasome inhibitor 
MG132) (lane 1), or both 50 μM MG132 and 0.5% DMSO (lane 2). The incubation was followed 
by preparation of extracts, SDS-PAGE and immunoblotting with anti-Flag antibody. Right panel: 
same procedures as in experiments of the left panel but with erg6Δ S. cerevisiae incubated in SD 
containing either 1% isopropanol (the solvent for a stock solution of phenylmethylsulfonyl fluoride 
(PMSF), an inhibitor of serine proteases) (lane 1), or both 1 mM PMSF and 1% isopropanol 
(lane 2). 
(E) Quantification of data in D, left panel. 
(F) Quantification of data in D, right panel. 
(G) CHX-chases with wt (lanes 1-3, 7-9) or naa20Δ (nat3Δ) (lanes 4-6, 10-12) S. cerevisiae 
strains expressing MD-Cog1
wt
 C-terminally tagged with three flag epitopes. Cells were grown for 
3 hrs in SD medium containing 0.003% SDS (to allow for the entry of MG132) and either 
0.5% DMSO (control, lanes 1-6) or both 50 μM MG132 and 0.5% DMSO. Note the metabolic 
stabilization of MD-Cog1
wt
 in wild-type cells by MG132 (lanes 1-3 vs. lanes 7-9) and the metabolic 
stabilization of MD-Cog1
wt
 in naa20Δ cells (lacking the NatB Nt-acetylase) irrespective of the 
absence or presence of MG132 (lanes 4-6 vs. lanes 10-12). 
(H) CHX-chases with either wt or uba1-204 S. cerevisiae (the latter containing a 
temperature-sensitive mutant of the Ub-activating (E1) enzyme (Ghaboosi and Deshaies, 2007)) 
expressing MD-Cog1
wt
 C-terminally tagged with three flag epitopes. Lanes 1-3, wt cells at 30°C. 
Lanes 4-5, uba1-204 cells at 30°C. Lanes 7-8, same as in lanes 1-3 but at 37°C (nonpermissive 
temperature for uba1-204 cells). Lanes 10-12, same as lanes 4-6 but at 37°C. Note the metabolic 
stabilization of MD-Cog1
wt
 in uba1-204 cells at 37°C (lanes 10-12). Figure S3 refers to Figure 1. 
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Figure S4. Antibody Specific for Nt-Acetylated Cog1, and Interactions of Nt-Acetylated and 
Unacetylated Cog1 with Subunits of the COG Complex or with Membranes. 
(A) Characterization of the anti-
AcNt
Cog1 antibody using a dot immunoassay. Increasing 
amounts of the Nt-acetylated Ac-MDEVLPLFRDSC peptide and its non-acetylated counterpart 
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MDEVLPLFRDSC were spotted onto a nitrocellulose membrane, followed by immunoblotting with 
the rabbit anti-
AcNt
Cog1 antibody that was raised against the Ac-MDEVLPLFRDSC peptide and 
was then affinity-purified both “positively” (against Ac-MDEVLPLFRDSC) and “negatively” 
(against MDEVLPLFRDSC) (see Extended Experimental Procedures). 
(B) Wt, cog1Δ, and naa20Δ (nat3Δ) S. cerevisiae strains overexpressed either MD-Cog1wt, 
P-Cog1, or ME-Tpk2 (an Nt-acetylated protein whose N-terminal sequence is different from that of 
MD-Cog1
wt
; a negative control) from the PCUP1 promoter on low copy plasmids. Equal amounts of 
total protein in the extracts were fractionated by SDS-PAGE and immunoblotted with the anti-
AcNt
Cog1 antibody. Lane 1, MD-Cog1
wt
 (C-terminally tagged with three flag epitopes) was 
expressed in wt cells. Lane 2, same as in lane 1 but the identically tagged P-Cog1 (MP-Cog1). Lane 
3, same as in lane 2 but in cog1Δ cells. Lane 4, same as in lane 1 but vector alone (no exogenously 
expressed MD-Cog1
wt
). Lane 5, ME-Tpk2 (C-terminally tagged with three flag epitopes) was 
expressed in wt cells. Lane 6, same as in lane 5 but ME-Tpk2 was expressed in naa20Δ (nat3Δ) 
cells lacking the cognate NatB Nt-acetylase. 
Anti-
AcNt
Cog1 detected the band of Nt-acetylated MD-Cog1
wt
 in lane 1. Consistently, there 
was virtually no signal in other lanes, except for the barely detectable band in lanes 4 and 5 (marked 
by asterisk on the right) that is likely to be the endogenous Nt-acetylated MD-Cog1
wt
 (endogenous 
MD-Cog1
wt
 was expressed at levels significantly below those of exogenous MD-Cog1
wt
). 
Consistent with the absence of three flag epitopes in the endogenous MD-Cog1
wt
, its band migrated 
faster than the band of the exogenous (tagged) MD-Cog1
wt
 (lane 1 vs. lanes 4 and 5). Note the 
absence of crossreaction of anti-
AcNt
Cog1 with Nt-acetylated ME-Tpk2 in wt cells (lane 5). The 
anti-
AcNt
Cog1 antibody also detected proteins larger than MD-Cog1
wt
; they are marked by green 
arrowheads on the left. These proteins were not derivatives of MD-Cog1
wt
, as they were present in 
cells not expressing MD-Cog1
wt
 (lane 4). The three proteins were Nt-acetylated by NatB, as they 
were absent in naa20Δ (nat3Δ) cells (lane 6). A likely and parsimonious interpretation is that the 
anti-
AcNt
Cog1 antibody detected three specific Nt-acetylated proteins whose cognate Nt-acetylase 
(NatB) is the same as the one that Nt-acetylates MD-Cog1
wt
 and whose N-terminal sequences are 
sufficiently close to that of MD-Cog1
wt
 to have resulted in a crossreaction. 
(C) Same as in B, but the same membrane was re-probed with anti-flag antibody, to detect 
the bulk of triply flag-tagged MD-Cog1
wt
 and ME-Tpk2. 
(D) Equal amounts of total detergent-free cell extracts from wt or naa20Δ (nat3Δ) 
S. cerevisiae were fractionated to yield the cytosolic (C) and membrane (M) fractions, followed by 
SDS-PAGE and immunoblotting with anti-flag antibody to detect the triply flag-tagged 
MD-Cog1
wt
. Lanes 1-3, wt total (T) extract and its C and M fractions, respectively. Lanes 4-6, same 
as in lanes 1-3 but from naa20Δ (nat3Δ) cells. 
(E) Coomassie Blue staining of membrane probed by anti-flag in D.  
(F) Quantification of the ratio of MD-Cog1
wt
 in the membrane versus cytosolic fractions in 
panel D, using Odyssey (Li-Cor) (see Extended Experimental Procedures). 
(G) Coimmunoprecipitation of MD-Cog1
wt
 and Cog3 in the presence and absence of 
Nt-acetylation. Wt and naa20Δ (nat3Δ) S. cerevisiae strains carried either a PCUP1 
promoter-containing low copy plasmid, or the otherwise identical plasmid expressing MD-Cog1
wt
 
(C-terminally tagged with three flag epitopes), or the plasmid expressing Cog3 (C-terminally 
ha-tagged), in the indicated combinations of test proteins and genetic backgrounds of strains in 
which they were expressed. Extracts from these strains were immunoprecipitated using anti-flag 
beads, followed by SDS-PAGE and immunoblotting with anti-ha (to detect Cog3; the upper panel, 
green color) or with anti-flag (to detect MD-Cog1
wt
; the lower panel, red color). As described in the 
main text, most Cog3 in naa20Δ (nat3Δ) cells was converted into a derivative of lower 
electrophoretic mobility, indicated on the right as “modified Cog3”. The asterisk on the left 
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indicates a protein crossreacting with anti-ha antibody. The arrowhead on the right marks the 
position of the heavy IgG chain, above the band of immunoprecipitated MD-Cog1
wt
. 
(H) Same as in G (including the same notations), but coimmunoprecipitation of MD-Cog1
wt
 
(C-terminally tagged with three flag epitopes) and Cog4 (C-terminally ha-tagged). The asterisk in 
the top panel on the right indicates a protein crossreacting with anti-ha. Figure S4 refers to Figures 1 
and 4. 
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Figure S5. Degradation of MD-Cog1wt by the Ac/N-End Rule Pathway in S. cerevisiae Mutants 
Lacking Specific E2 or E3 enzymes. 
(A) CHX-chases with yeast mutants in specific Ub-conjugating (E2) enzymes that expressed 
MD-Cog1
wt
 C-terminally tagged with three flag epitopes. Wt S. cerevisiae (lanes 1-3) and mms2Δ 
(lanes 4-6), rad6Δ (lanes 7-9), ubc5Δ (lanes 10-12), ubc8Δ (lanes 13-15), and ubc10Δ (lanes 16-18) 
mutants. 
(B) Same as in A but with S. cerevisiae mutants ubc4Δ (lanes 1-3), ubc6Δ (lanes 4-6), ubc7Δ 
(lanes 7-9), ubc11Δ (lanes 10-12), ubc12Δ (lanes 13-15), and ubc13Δ (lanes 16-18). 
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(C) Same as in A but with wt (lanes 1-3) and ubc1Δ (lanes 4-6) S. cerevisiae. 
(D) CHX-chases with mutants in two specific E3 enzymes. Same as in A but with 
wt (lanes 1-3), doa10Δ (lanes 4-6), and san1Δ (lanes 7-9) S. cerevisiae strains. 
(E) Same as in D but the chases for 30 and 60 min with wt (lanes 1-3), ubr1Δ (lanes 4-6), 
doa10Δ (lanes 7-9), and double-mutant ubr1Δ doa10Δ (lanes 10-12) S. cerevisiae strains. 
(F) Lanes 1-4, 
35
S-pulse chase with wt S. cerevisiae and MD-Cog1
wt
 (C-terminally tagged 
with three flag epitopes modified to contain a Met residue in each epitope, to increase 
35
S in Cog1; 
see Extended Experimental Procedures). Lanes 5-8, same as lanes 1-4 but with a double mutant 
ubc6Δ ubc7Δ. 
(G) Quantification of 
35
S-pulse-chase data in F. 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES 
 
Yeast Strains, Media, and Genetic Techniques 
S. cerevisiae strains used in this study are described in Table S1. Standard techniques 
(Ausubel et al., 2010; Sherman, 1991) were employed for strain construction and transformation. 
S. cerevisiae media included YPD (1% yeast extract, 2% peptone, 2% glucose; only most relevant 
components are cited); SD medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 2% 
glucose); and synthetic complete (SC) medium (0.17% yeast nitrogen base, 0.5% ammonium sulfate, 
2% glucose), plus a drop-out mixture of compounds required by a given auxotrophic strain. The 
COG1-3HA strains were made by standard PCR of the 3HA-HIS3MX6 module (Longtine et al., 
1998) targeted to the 3’ coding region of COG1. The PCR product was transformed into BY4742, 
BY17299, and BY15546 to create ASY101, ASY102, and ASY103, respectively. The double 
mutant ubc6Δubc7Δ (ASY104) was made by transforming BBY67.3 with a PCR product of the 
KanMX6 module (Longtine et al., 1998) targeted to the 5’ and 3’ regions of UBC7, thereby 
replacing the ORF of Ubc7 with KanMX6. The ASY105 strain was made by the standard 
integration of a PCR fragment derived from pFA6a-13MYC with the HIS3MX6 marker targeted to 
the 3' end of the COG1 gene. Proper tagging of COG1 and its product was verified by PCR and 
immunoblotting with anti-myc antibody. The resulting ASY105 strain was transformed with 
pAS118 or the control YEPlac181 plasmid (Table S2). E1, E2, E3 and Nt-acetylase mutant strains 
used in this study were from the Varshavsky lab stock (CHY345, CHY346, BBY67.3), the 
T. Sommer lab stock (YW05), the Deshaies lab stock (RJD3268, RJD3269) or all others from Open 
Biosystems. Strains used in the proteasome and vacuole inhibitor studies were obtained from Open 
Biosystems (BY10568) or from the Varshavsky lab stock (JD52, CHY49). The cog1Δ mutant 
(BY14589) was obtained from Open Biosystems.  
 
Construction of Plasmids 
The S. cerevisiae Cog1-coding sequence was amplified by PCR from genomic DNA and the 
triple flag-coding sequence was then added by PCR. Additional Met-coding sequences were added 
in between the Cog1-coding sequence and the triple flag-coding sequence to increase the labeling of 
MD-Cog1
wt
 with 
35
S-Met. The 3 extra Met-coding DNA sequences were separated by short Gly-Ser 
linker sequences, the complete Met-enriching sequence being MSGMGAM. pAS101 was 
constructed  by ligating the BamHI/Not1 digested PCR fragment of Cog1-3flag DNA into the 
low-copy (CEN) plasmid pRS316 with the PCUP1 promoter (p316Cup1). pAS117 was made by 
standard site-directed mutagenesis of pAS101 to insert a coding sequence for proline (P) in between 
the initiator Met (M) and Asp (D). pAS105 was made by amplifying the Cog1-coding sequence 
with a sequence encoding a single C-terminal ha tag and ligating this PCR product into the 
BamHI/NotI-cut p316Cup1 plasmid. pAS118 was made by standard point mutagenesis of pAS105 
to mutate the aspartic acid (D) coding sequence to lysine (K). pAS102 was made by adding the 
3flag sequence to the 3’ end of the Cog2 PCR product and ligating that product into p316Cup1. 
pAS115 was made by inserting the Cog2-3f sequence and the Cog3-HA sequence on opposite sides 
of the PGAL1/10 bidirectional promoter. pAS116 was made by inserting the Cog4-ha-coding sequence 
into pRS425Gal1/10. pAS118 was made by ligating the XbaI/PstI-derived, PCR-produced DNA 
fragment into XbaI/PstI-cut pRB208. 
To construct pAS112 (Table S2), the S. pombe HCN1 coding sequence was amplified from 
pGAD424-Hcn1. The triple flag-coding DNA sequence was then added to the 3’ region of HCN1. 
The resulting PCR-produced DNA fragment was ligated into the high copy plasmid pRS423 
(Ausubel et al., 2010) containing the PCUP1 promoter. The same PCR fragment from pAS112 was 
ligated into p413Met25 to produce pAS113. The S. cerevisiae DNA encoding Cdc26 was amplified 
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from genomic DNA and the triple flag-coding DNA sequence was added by PCR. The resulting 
DNA fragment was cloned into pRS423 as described above to produce pAS119. DNA encoding 
S. pombe Cut9 was amplified from pGAD424-Cut9, and the triple flag-coding DNA sequence was 
added to the 3’ region of CUT9 by PCR. The resulting DNA fragment was ligated into the high 
copy pRS425 plasmid containing the PGAL1 promoter, yielding pAS114.  
 
Cycloheximide Chase Degradation Assays 
S. cerevisiae were grown to A600 of 0.8 to 1.0 in plasmid-maintaining (selective) liquid 
media at 30°C, followed by treatment with cycloheximide (CHX), at the final concentration of 
0.1 mg/ml. At indicated times, cell samples (corresponding to 1 ml of cell suspension at A600 of 1) 
were harvested by centrifugation for 1 min at 11,200g, and resuspended in 1 ml of 0.2 M NaOH, for 
20 min on ice, or for 5 min at room temperature, followed by centrifugation for 1 min at 11,200g. 
Pelleted cells were resuspended in 50 μl of 1X LDS buffer (Invitrogen, Carlsbad, CA) with 1X 
reducing agent and 1x protease inhibitor cocktail “for use with fungal and yeast extracts” (Sigma), 
and heated for 10 min at 70°C. After centrifugation at 5 min at 11,200g, 10 μl of supernatant was 
fractionated by SDS-4-12% NuPAGE, followed by immunoblotting with an appropriate antibody. 
The antibodies used included anti-ha (Sigma), anti-flag (Stratagene, La Jolla, CA), anti-tubulin 
(used for loading controls) (Sigma), and anti-
Nt
Cog1, prepared and purified as described below. 
Immunoblots were processed using secondary antibodies labeled with different fluorophores. 
Visualized protein bands were quantified using the Odyssey Imaging System (Li-Cor, Lincoln, NE). 
The near-infrared fluorescence range and other features of the Odyssey scanner facilitate 
quantification of immunoblots. 
All immunoblotting experiments (Figures 1-5, S3-S5) involved, in addition to explicitly 
shown data, specific loading controls that utilized immunoblotting with an antibody to tubulin 
(Hwang et al., 2010b) as shown in Figure 5A, and/or the staining of membranes with Coomassie 
after protein transfer.  
 
 
35S-Pulse-Chase Degradation Assays 
These experiments were performed essentially as described previously (Hwang et al., 2009; 
Hwang et al., 2010a; Hwang et al., 2010b). Unless stated otherwise, S. cerevisiae strains were 
grown at 30C to A600 of ~1 in 10 ml of SD medium with components required for auxotrophic 
growth. Cells were pelleted by centrifugation, gently resuspended, and washed in 0.8 ml of SD 
medium with required amino acids but without L-Met and L-Cys. Cell pellets were gently 
resuspended again in 0.4 ml of the same medium and labeled for 5 min at 30°C with 0.16 mCi of 
35
S-EXPRESS (Perkin-Elmer). Cells were pelleted again and resuspended in 0.3 ml of SD medium 
containing unlabeled 10 mM L-Met, 5 mM unlabeled L-Cys, and required amino acids. Samples 
(0.1 ml) were taken at the indicated time points, followed by preparation of extracts by bead beating 
(FastPrep, 20 seconds at 6.5 M/s, 4 times each), immunoprecipitation with anti-flag magnetic beads 
(Sigma), SDS-4-12% NuPAGE, electrophoretic transfer of proteins to a PVDF membrane 
(Invitrogen) and autoradiography. Quantification of 
35
S-pulse-chases was carried out using Storm 
PhosphorImager and ImageQuant (GE Healthcare, Pittsburgh, PA). 
 
Antibody Specific for Nt-Acetylated Cog1 
Ac-MDEVLPLFRDS, the Nt-acetylated N-terminal peptide of MD-Cog1
wt
, was used to 
produce a rabbit antibody, termed anti-Cog1
AcNt
, that recognized Ac-MDEVLPLFRDS but not its 
unacetylated counterpart (Figures 1E-H and S4A-C). The Nt-acetylated synthetic peptide 
AcMDEVLPLFRDSC and its unacetylated counterpart MDEVLPLFRDSC (they bore C-terminal 
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Cys for crosslinking these peptides to the keyhole limpet hemocyanin carrier protein) were 
synthesized and purified by Abgent (San Diego, CA). Standard procedures were employed by 
Abgent to produce rabbit antisera to AcMDEVLPLFRDSC. The resulting antibody (its IgG 
fraction, produced using immobilized Protein A) was affinity-purified, “positively” at first, against 
the immobilized AcMDEVLPLFRDSC peptide. The peptide-bound antibody was eluted and 
thereafter “negatively” purified against the MDEVLPLFRDSC peptide (immobilized using 
SulfoLink Coupling Resin (Pierce)), with collection, this time, of the unbound antibody fraction. 
The resulting antibody, termed anti-
AcNt
Cog1, was highly specific for Nt-acetylated MD-Cog1
wt
 
(see Results). Immunoblotting with anti-
AcNt
Cog1 (1:500 dilution) was carried out for 3 h at room 
temperature (RT) in 5% skim milk in PBST (PBS containing 0.5% Tween-20). The bound 
anti-
AcNt
Cog1 was detected using the Odyssey Imaging System and a goat anti-rabbit antibody 
(at 1:5,000 dilution) that was conjugated to IRDye-800 (Li-Cor). 
 
Partitioning of Nt-Acetylated and Unacetylated MD-Cog1wt Between Membranes and 
Cytosol  
This assay (Figure S4D-F) used a slight modification of the previously described procedure 
(Fotso et al., 2005). Wild-type and naa20Δ (nat3Δ) S. cerevisiae expressing MD-Cog1wt 
(C-terminally tagged with three flag epitopes) were grown at 30°C in 200 ml of SD to A600 
between 1 and 2. Cells were collected by centrifugation and washed twice with ice-cold distilled 
water. Cells were disrupted in 1 ml of lysis buffer (1 mM dithiothreitol (DTT), 20 mM HEPES, 
(pH 7.0), 1 mM PMSF, and protease inhibitor cocktail (Sigma)), using 1 ml of glass beads and 
vortexing 3 times for 1 min each. The extract was clarified by centrifugation at 3000g for 5 min, 
followed by centrifugation in the TL100 ultracentrifuge (Beckman) at 150,000g for 1 h to obtain 
crude “cytosolic” (supernatant) and “membrane” (pellet) fractions. Membrane fractions were 
resuspended in 1 ml of Tris-Buffered Saline (TBS). Total clarified extracts and equal total protein 
amounts of cytosolic and membrane fractions (as determined by the Bradford assay) were 
fractionated by SDS-4-12% NuPAGE (Invitrogen), followed by immunoblotting with anti-flag 
antibody. The relative amounts of MD-Cog1
wt
 in cytosolic and membrane fractions were quantified 
using the Odyssey Imaging System.  
 
Coimmunoprecipitation of Cog1 with Cog3 and Cog4 
Wild-type and naa20Δ (nat3Δ) S. cerevisiae expressing specific combinations of either 
vector alone, MD-Cog1
wt
 (C-terminally tagged with three flag epitopes), Cog3 (C-terminally 
ha-tagged), or Cog4 (C-terminally ha-tagged) (Figure S4G, H) were grown at 30°C to A600 of 
~1 in 50 ml of SD containing or lacking appropriate metabolic markers. Cells were collected by 
centrifugation and resuspended in 0.8 ml of lysis buffer (0.1% NP-40, 10% glycerol, 0.1 M NaCl, 
0.5 mM EDTA, 25 mM HEPES, pH 7.5) containing 1X protease inhibitor cocktail and 1 mM 
PMSF. Cells were disrupted using the FastPrep lysing matrix and bead beating (FastPrep). The 
extract was clarified by centrifugation at 12,000g for 15 min at 4°C. The total protein concentration 
was measured by the Bradford assay. Equal amounts of total protein were incubated with anti-flag 
magnetic beads (Sigma) for 2 hrs at 4°C. The beads were washed 3 times with lysis buffer, followed 
by the elution of beads-bound proteins with 12 μl of 2X NuPAGE LDS sample buffer (containing 
lithium dodecyl sulfate instead of SDS) with protease inhibitors. Sample were heated at 95°C for 
5 min, clarified by centrifugation, and fractionated by SDS-4-12% NuPAGE, followed by 
immunoblotting with anti-ha antibody and thereafter with anti-flag antibody.  
 
Assays with Protease Inhibitors  
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MD-Cog1
wt
 C-terminally tagged with three flag epitopes was expressed from the low copy 
plasmid pRS316Cup1-Cog1-3flag and its PCUP1 promoter in pdr5Δ S. cerevisiae (the absence of the 
Pdr5 pump in this mutant allowed for the intracellular retention of MG132, a proteasome inhibitor). 
Cells were incubated for 1 hr in SD medium containing either 0.5% dimethylsulfoxide (DMSO) (the 
solvent for a stock solution of MG132), or both 50 μM MG132 and 0.5% DMSO. The incubation 
was followed by preparation of extracts, SDS-PAGE and immunoblotting with anti-flag antibody. 
The same procedures were employed using erg6Δ S. cerevisiae to examine effects of 
phenylmethylsulfonyl fluoride (PMSF), an inhibitor of serine proteases, on the degradation of 
MD-Cog1
wt
. Cells were incubated either in the presence of 1% isopropanol (the solvent for a stock 
solution of PMSF), or both 1 mM PMSF and 1% isopropanol, followed by preparation of extracts, 
SDS-PAGE and immunoblotting with anti-flag antibody (Figure S3D-F).  
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Table S1: S. cerevisiae Strains Used in This Study 
Strain Relevant Genotype Source 
BY4742 MATα his3-1 leu2-0 lys2-0 ura3-0 can1-100, Open Biosystems 
BY10976 ard1Δ::KanMX6 in BY4742 Open Biosystems 
BY15470 mak3Δ::KanMX6 in BY4742 Open Biosystems 
BY15546 nat3Δ::KanMX6 in BY4742 Open Biosystems 
BY17299 doa10Δ:KanMX6 in BY4742 Open Biosystems 
BY4741 MATa his3-1 leu2-0 met15-0 ura3-0 Open Biosystems 
BY4425 rad6Δ:: KanMX4 in BY4741 Open Biosystems 
BY14589 cog1Δ::KanMX4 in BY4742 Open Biosystems 
ASY101 COG1-3HA::HIS3MX6 in BY4742 This Study 
ASY102 COG1-3HA::HIS3MX6 in BY17299 This Study 
ASY103 COG1-3HA::HIS3MX6 in BY15546 This Study 
ASY105 COG1-13MYC::HIS3MX6 in BY4742 This Study 
YW05 ubc1Δ:: HIS3 JD52 T. Sommers lab 
collection 
BY4454  mms2Δ::KanMX6 in BY4741 Open Biosystems 
BY3994 ubc5Δ::KanMX6 in BY4741 Open Biosystems 
BY3219 ubc4Δ::KanMX6 in BY4741 Open Biosystems 
BBY67.3 ubc6Δ::HIS3 in JD52 Varshavsky lab 
collection 
BY597 ubc7Δ::KanMX6 in BY4741 Open Biosystems 
BY6577 ubc8Δ:: KanMX6 in BY4741 Open Biosystems 
BY4763 ubc10Δ:: KanMX6 in BY4741 Open Biosystems 
BY1636 ubc11Δ:: KanMX6 in BY4741 Open Biosystems 
BY5214 ubc12Δ:: KanMX6 in BY4741 Open Biosystems 
BY4027 ubc13Δ:: KanMX6 in BY4741 Open Biosystems 
AS104 ubc6Δ::HIS3, ubc7Δ::KanMX6 in JD52 This Study 
BY10568 erg6Δ::KanMX6 in BY4742 Open Biosystems 
RJD3268 MATa, uba1::KANMX [pRS313 - UBA1-HIS], can1-100, 
leu2-3, -112, his3-11, -15, trp1-1, ura3-1, ade2-1 
(Ghaboosi and 
Deshaies, 2007) 
RJD3269  MATa, uba1Δ::KanMX [pRS313-uba1-204-HIS], can1-
100, leu2-3, -112, his3-11, -15, trp1-1, ura3-1, ade2-1 
(Ghaboosi and 
Deshaies, 2007) 
JD52 MATa trp1- 63 ura3-52 his3- 200 leu2-3112. lys2-801 (Hwang et al., 
2010b) 
CHY49 pdr5Δ::KanMX6 in JD52 (Dohmen et al., 
1995) 
CHY345 ubr1Δ::LEU2 in BY4742 This Study 
CHY346 ubr1Δ::LEU2 doa10Δ::KANMX6 in BY4742 This Study 
AS106 not4Δ::HIS3MX6 in BY4742 This Study 
AS107 not4Δ::HIS3MX6 doa10Δ::KANMX6  in BY4742 This Study 
AS108 not4Δ::HIS3MX6 ubr1Δ::LEU2  in BY4742 This Study 
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Table S2: Plasmids Used in This Study 
Plasmid Description Source 
p316Cup1 pRS316 with PCUP1 promoter This study 
p313Cup1 pRS313 with PCUP1 promoter This study 
pAS101 Cog1-3flag in p316CUP1 This study 
pAS117 MPCog1-3flag in p316Cup1 This study 
pAS102 Cog2-3flag in p316CUP1 This study 
pAS103 Cog1-3flag in p313CUP1 This study 
pAS104 Cog1-3HA in p316CUP1 This study 
pAS105 Cog1-HA in p316CUP1 This study 
pAS106 Cog3-HA in p316CUP1 This study 
pAS107 Cog4-HA in p316CUP1 This study 
pAS108 Cog5-HA in p316CUP1 This study 
pAS109 Cog6-HA in p316CUP1 This study 
pAS110 Cog8-HA in p316CUP1 This study 
pAS111 Cog1-3flag in p425GAL1 This study 
p413MET25 pRS413 with PMET25 promoter (Mumberg et al., 1994) 
pAS112 Hcn1-3flag in p423CUP1 This study 
pAS113 Hcn1-3flag in p413MET25 This study 
p425Gal1 pRS425 with PGAL1 promoter (Mumberg et al., 1994) 
pAS114 Cut9-3flag in p425GAL1 This study 
pAS115 Cog2-3flag, Cog3-HA in p423GAL1,10 This study 
pAS116 Cog4-HA in p425GAL1,10 This study 
pAS118 Cog1-3flag in YEPlac181 with pAdh1 This study 
YEPlac181 2μ LEU2 plasmid Varshavsky lab collection 
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